Get new exclusive access to healthcare business reports & breaking news
In 2018, an estimated 1.73 million Americans were diagnosed with cancer. Almost 40% of men and women will be diagnosed with cancer at some point during their lifetimes. National expenditures tied to cancer care topped 147 billion dollars (with a B!) last year.
Despite the high prevalence of cancer in our society, we are profoundly unequipped – at a national and personal level – to deal with this terrible disease. Living (and dying) with cancer is not only about the quality of care a patient receives from healthcare professionals (doctors, nurses, technicians etc). Cancer is a life altering event and most of us do not know how to deal with it in our personal lives (with our friends, family members or in relation to our co-workers).
Learning that you’ve been diagnosed with cancer impacts every aspect of your life – from our perspective on the future, to our daily routines and our work/ personal lives. But most importantly, cancer throws victims into a constant state of uncertainty.
One company, Helpsy, has taken on the ambitious goal of helping cancer survivors deal with their diagnostics, learn more about their condition, and creating daily routines: medication adherence, drug side effects, doctor appointments and much more.
In our new ‘Healthcare Weekly: At the Forefront of Healthcare Innovation’ podcast, Codrin Arsene, CEO @ Healthcare Weekly talks to Sangeeta Agarwal, CEO at Helpsy about this amazing new Artificial Intelligence enabled solution. Helpsy’s new technology, the San bot, becomes the smart virtual assistant for every cancer patient looking for guidance and support through the challenging battle of fighting and hopefully overcoming cancer.
Subscribe to‘Healthcare Weekly: At the Forefront of Healthcare Innovation’ podcast on your favorite podcast network, today! New episodes released every week.
Interested to learn more about Artificial Intelligence in Healthcare? Check out our ultimate guide to how AI is currently leveraged across the industry.